VAERS reports by lot

Janssen (J&J) COVID-19 lot 202AZ1A: VAERS reports

21 VAERS reports list lot 202AZ1A as a Janssen (J&J) COVID-19 vaccine, received between 2021-04-11 and 2021-10-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
10%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2122%
Neurological1718%
Musculoskeletal1616%
Gastrointestinal99%
Respiratory88%
Cardiac / Cardiovascular66%
Allergic / Anaphylactic66%
Dermatological (non-injection-site)66%
Injection-site / Local reaction55%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 9).

New York5
Arizona5
Pennsylvania2
District of Columbia2
Washington2
Florida2
Colorado1
Maine1
Oregon1

Reports by month received

2021-048
2021-053
2021-061
2021-083
2021-094
2021-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.